ACM
GSK icon

Americafirst Capital Management’s GSK GSK Stock Holding History

Americafirst Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,547
Closed -$299K – 209
2017
Q2 		$299K Buy
+5,547
New +$296K 0.38% 92
2014
Q4 		– Sell
-12,874
Closed -$740M – 252
2014
Q3 		$740M Buy
+12,874
New +$789K 0.36% 96

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Americafirst Capital Management's GSK Position: Q3 2017 in Review

Americafirst Capital Management sold out of GSK (GSK) in Q3 2017, closing a stake of 5,547 shares — an estimated $299K sold.

Americafirst Capital Management first reported a position in GSK in Q3 2014 and held it in 2 quarters. The position peaked at $740M in Q3 2014. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Americafirst Capital Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 5,547 GSK shares in Q3 2017, an estimated $299K.
  • Americafirst Capital Management first reported a position in GSK in Q3 2014 and held it in 2 quarters.
  • Americafirst Capital Management's GSK position peaked at $740M in Q3 2014.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.